Sucampo Pharmaceuticals

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) is a global biopharmaceutical company focused on innovative research and development of proprietary drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. Sucampo has a marketed product - AMITIZA® - and a pipeline including lifecycle management and clinical development programs. Sucampo is headquartered in Rockville, Maryland, and has operations in Japan, Switzerland and the United Kingdom.

Type
Public
HQ
Rockville, US
Founded
1996
Employees
159 (est)+99%

Sucampo Pharmaceuticals Locations

Rockville, US
Kita Ward, JP
Zug, CH
Chiyoda, JP
Chuo Ward, JP
Sanda-shi, JP
Milton, GB

Sucampo Pharmaceuticals Metrics

Sucampo Pharmaceuticals Summary

Founding Date

1996

Market capitalization

$662 M

Closing share price

$15.8

Sucampo Pharmaceuticals Market Value History

Sucampo Pharmaceuticals News

Sucampo Pharmaceuticals Company Life

You may also be interested in